Pfizer and BioNTech said Wednesday that laboratory tests suggest that their coronavirus vaccine is effective against the Omicron variant after three doses, adding that just two doses “may not be sufficient to protect against infection”. We’ll get the latest on Covid research and treatment and take your coronavirus questions with Bob Wachter, chair of UCSF’s Department of Medicine.

Learn more about your ad choices. Visit megaphone.fm/adchoices